英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
deneer查看　deneer　在百度字典中的解释百度英翻中〔查看〕
deneer查看　deneer　在Google字典中的解释Google英翻中〔查看〕
deneer查看　deneer　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • List of 81 Plaque Psoriasis Medications Compared - Drugs. com
    Plaque psoriasis (psoriasis vulgaris) is the most common form of psoriasis and treatment options include topical therapy, light therapy, and oral or injected medications Topical treatments for plaque psoriasis include: Corticosteroids: These are frequently prescribed for mild to moderate plaque psoriasis and are available as oils, ointments, creams, lotions, gels, foams, sprays, and shampoos
  • What are the new drugs for plaque psoriasis?
    Other new systemic treatments for plaque psoriasis are the interleukin-23 antagonists risankizumab (Skyrizi), tildrakizumab (Ilumya), and guselkumab (Tremfya) Interleukin-23 antagonists work by blocking interleukin-23 (IL-23), a pro-inflammatory cytokine thought to play a major role in chronic immune-mediated diseases, including plaque psoriasis
  • List of 204 Psoriasis Medications Compared - Drugs. com
    Compare risks and benefits of common medications used for Psoriasis Find the most popular drugs, view ratings and user reviews
  • Psoriasis Guide: Causes, Symptoms and Treatment Options
    Psoriasis - an easy to understand guide covering causes, diagnosis, symptoms, treatment and prevention plus additional in depth medical information
  • FDA Approves Tremfya (guselkumab) for the Treatment of Pediatric Plaque . . .
    All News Consumer Pro New Drugs Pipeline Clinical Trials FDA Alerts FDA Approves Tremfya (guselkumab) for the Treatment of Pediatric Plaque Psoriasis and Active Psoriatic Arthritis HORSHAM, PA, (September 29, 2025) – Johnson Johnson (NYSE: JNJ) today announced that the U S Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for the treatment of children six years and
  • U. S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for . . .
    The FDA first approved Sotyktu in 2022 for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
  • Psoriasis 101: Causes, Symptoms and Treatments, Explained
    A dermatologist can diagnose psoriasis and help develop a treatment plan tailored to your needs Psoriasis is a lifelong condition, but with the right care, most people can manage their symptoms and live comfortably Understanding your type of psoriasis, identifying triggers and following your treatment plan can make a big difference
  • Psoriasis - What You Need to Know - Drugs. com
    Care guide for Psoriasis Includes: possible causes, signs and symptoms, standard treatment options and means of care and support
  • What are IL-17 Inhibitors and how do they work? - Drugs. com
    It is currently approved for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and hidradenitis suppurativa How IL-17 Inhibitors are Given All IL-17 inhibitors are injected under the skin, either by prefilled syringe or auto-injector devices
  • Ilumya: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques, scales, and redness Includes Ilumya side effects, dose, uses and more





中文字典-英文字典  2005-2009